Drug – bio-affecting and body treating compositions – Immunoglobulin – antiserum – antibody – or antibody fragment,... – Free from infectious agents
Reexamination Certificate
2005-01-07
2011-12-27
Kim, Yunsoo (Department: 1644)
Drug, bio-affecting and body treating compositions
Immunoglobulin, antiserum, antibody, or antibody fragment,...
Free from infectious agents
C424S177100
Reexamination Certificate
active
08084032
ABSTRACT:
The present invention provides a method of purifying an antibody by protein A affinity chromatography. More specifically, the present invention provides a technique relating to an elution buffer solution which provides a good antibody recovery rate without denaturation.
REFERENCES:
patent: 6171586 (2001-01-01), Lam et al.
patent: 0 310 719 (1989-04-01), None
patent: 2-273194 (1990-11-01), None
patent: WO 94/07912 (1994-04-01), None
patent: WO 02/098531 (2002-12-01), None
Protein Purification Handbook (1999, p. 1-27,29-59,61-97, Amersham Pharmacia Biotech).
Tsumoto et al. (Biotechnol. Prog. 2004, 20:1301-1308).
Arakawa et al., Biochem. Biophysical Research Communications 304, 2003, p. 148-152.
Uemura, Tohoku J. Exp. Med, 1983, vol. 141, 337-349.
Arakawa, T., et al., “Elution of antibodies from a Protein-A column by aqueous arginine solutions,” Protein Expression and Purification 2004;36:244-248.
Bywater, R., et al., “Elution of Immunoglobulins from Protein A—Sepharose® CL4B Columns,” 1976 Meeting Proceedings, vol. 2, pp. 337-340.
“Strategies for antibody purification,” Life Science News, Amersham Biosciences 2002;12:1-2.
Kent, U. M., Methods in Molecular Biology, col. 115, 1999, pp. 29-33, XP008043501 Totowa, NJ, US.
Notification of Reason for Rejection for Japanese Patent App. No. 2005-013897 (Sep. 16, 2010) with English translation thereof.
Arora, D., et al., “Method for increasing the yield of properly folded recombinant human gamma interferon from inclusion bodies,” (1996) J. Biotechnol. 52, 127-133.
Boschetti, E., “Antibody separation by hydrophobic charge induction chromatography,”(2002) Trends Biotechnol. 20, 333-337.
Brinkmann, U., et al., “Independent domain folding ofPseudomonasexotoxin and single-chain immunotoxins: influence of interdomain connections,” (1992) Proc. Natl. Acad. Sci. USA. 89, 3075-3079.
Brown, N. L., et al., “A study of the interactions between an IgG-binding domain based on the B domain of staphylococcal protein a and rabbit IgG,” (1998) Mol. Biotech. 10, 9-16.
Buchner, J., et al., “Alternatively folded states of an immunoglobulin,” (1991) Biochemistry 30, 6922-6929.
Buchner, J., “Renaturation, purification and characterization of recombinant Fab-fragments produced inEscherichia coli,” (1991) Bio/Technology 9, 157-162.
Calmettes, P., et al., “Temperature and pH dependence of immunoglobulin G conformation,” (1991) Arch. Biochem. Biophys. 291, 277-283.
Fahrner, R. L., et al., “Performance comparison of protein A affinity-chromatography sorbents for purifying recombinant monoclonal antibodies,” (1999) Biotech. Appl. Biochem., 30, 121-128.
Gülich, S., et al., “Protein engineering of an IgG-binding domain allows milder elution conditions during affinity chromatography,” (2000) J. Biotechnol. 76, 233-244.
Gupta, R. C., et al., “Isolation of circulating immune complexes by conglutinin and separation of antigen from dissociated complexes by immobilized protein A,” (1981) Clin. Exp. Immunol. 46, 9-19.
Hanh, R., et al., “Comparison of protein A affinity sorbents,” (2003) J. Chromatogr. B., 790, 35-51.
Jiskoot, W., et al.., “Non-random conformation of a mouse IgG2amonoclonal antibody at low pH,” (1991) Eur. J. Biochem., 201, 223-232.
Jiskoot, W., et al., “Analytical approaches to the study of monoclonal antibody stability,” (1990) Pharm. Res. 7, 1234-1241.
Li, R., et al., “Design, synthesis, and application of a protein A mimetic,” (1998) Nat. Biotechnol. 16, 190-195.
Martsev, S. P., et al., “Large increase in thermal stability of CH2 domain of rabbit IgG after acid treatment as evidenced by differential scanning calorimetry, ” (1994) Immunol. Lett. 43, 149-152.
Martsev, S. P., et al., “Thermodynamic and functional characterization of a stable IgG conformer obtained by renaturation from a partially structured low pH-induced state,” (1995) FEBS Lett. 361, 173-175.
Narhi, L., et al., “Effect of three elution buffers on the recovery and structure of monoclonal antibodies,” Anal. Biochem. 253 (1997), 236-245.
Paborji, M., et al., “Chemical and physical stability of chimeric L6, a mouse-human monoclonal antibody,” (1994) Pharm. Res. 11, 764-771.
Sarciaux, J. M., et al., “Effects of buffer composition and processing conditions on aggregation of bovine IgG during freeze-drying,” (1999) J. Pharm. Sci. 88, 1354-1361.
Shiraki, K., et al., “Biophysical effect of amino acids on the prevention of protein aggregation,” (2002) J. Biochem. 132,591-595.
Thies, M. J. W., et al., “The alternatively folded state of the antibody CH3 domain,” (2001) J. Mol. Biol. 309, 1077-1085.
Tsumoto, K., et al., “Practical considerations in refolding proteins from inclusion bodies,” (2003) Protein Expr. Purif. 28, 1-8.
Tsumoto, K., et al., “Solubilization of active green fluorescent protein from insoluble particles by guanidine and arginine,” (2003) Biochem. Biophys. Res. Commun. 312, 1383-1386.
Varady, L., et al., “Rapid high-performance affinity chromatography on micropellicular sorbents,” (1988) J. Chromatogr. 458, 207-215.
Verdoliva, A., et al., “Affinity purification of polyclonal antibodies using a new all-D synthetic peptide ligand: comparison with protein A and protein G,” (2002) J. Immunol. Methods 271, 77-88.
Vermeer, A. W. P., et al., “The thermal stability of Immunoglobulin: Unfolding and aggregation of a multi-domain protein,” (2000) Biophys. J. 78, 394-404.
Vlasov, A. P., et al., “Non-native conformational states of immunoglobulins: Thermodynamic and functional studies of rabbit IgG,” (1996) Biochemistry (Moscow) 61, 155-171.
Welfle, K., et al., “Conformation, pH-induced conformational changes, and thermal unfolding of anti-p24 (HIV-1) monoclonal antibody CB4-1 and its Fab and Fc fragments,” (1999) Biochim Biophys. Acta 1431, 120-131.
Arakawa Tsutomu
Ejima Daisuke
Yumioka Ryosuke
Ajinomoto Co. Inc.
Cermak Shelly Guest
Cermak Nakajima LLP
Kim Yunsoo
LandOfFree
Purification method which prevents denaturation of an antibody does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Purification method which prevents denaturation of an antibody, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Purification method which prevents denaturation of an antibody will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-4303490